Advertisement
Screener

Monopar Therapeutics Inc. (MNPR) Subsidiaries

Monopar Therapeutics Inc. Subsidiaries

Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (7 lists). Names and jurisdictions are as filed.

  • 2026-03-27: Subsidiary Monopar Therapeutics Australia Ltd Pty; Jurisdiction Australia.
  • 2026-03-27: Subsidiary Monopar Therapeutics, SARL; Jurisdiction France.
  • 2025-03-31: Subsidiary Monopar Therapeutics Australia Ltd Pty; Jurisdiction Australia.
  • 2025-03-31: Subsidiary Monopar Therapeutics, SARL; Jurisdiction France.
Annual report filedSubsidiaryJurisdiction
2026-03-27Monopar Therapeutics Australia Ltd PtyAustralia
2026-03-27Monopar Therapeutics, SARLFrance
2025-03-31Monopar Therapeutics Australia Ltd PtyAustralia
2025-03-31Monopar Therapeutics, SARLFrance
2024-03-28Monopar Therapeutics Australia Ltd PtyAustralia
2024-03-28Monopar Therapeutics, SARLFrance
2023-03-23Monopar Therapeutics Australia Ltd PtyAustralia
2023-03-23Monopar Therapeutics, SARLFrance
2022-03-24Monopar Therapeutics Australia Ltd PtyAustralia
2022-03-24Monopar Therapeutics, SARLFrance
2021-03-25Monopar Therapeutics Australia Ltd PtyAustralia
2021-03-25Monopar Therapeutics, SARLFrance
2020-03-27Monopar Therapeutics Australia Ltd PtyAustralia
2020-03-27Monopar Therapeutics, SARLFrance

Similar stocks

Stock NameCountryMarket CapPE Ratio
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B